secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2026-07-13T20:30:43+00:00
Accession:  0001213900-26-077591
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds Pharmaceuticals announces 1-for-10 reverse stock split effective July 24, 2026
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-10 ratio, effective 12:01 a.m. ET on July 24, 2026.
- Stock will trade on NYSE American under symbol APUS on split-adjusted basis from July 24.
- New CUSIP number for post-split common stock is 03771D201.
- Previously expected effective date of March 26, 2026, was delayed; now set for July 24, 2026.
- Every ten pre-split shares will combine into one post-split share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026077591/0001213900-26-077591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026077591/ea0297843-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-077591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer